{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T20:28:50Z","timestamp":1794428930339,"version":"4.9.1"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"am","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.radonc.2023.109589","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T20:30:36Z","timestamp":1685565036000},"page":"109589","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["ESGO\/ESTRO quality indicators for radiation therapy of cervical cancer"],"prefix":"10.1016","volume":"183","author":[{"given":"Cyrus","family":"Chargari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Tanderup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Planchamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Chiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Humphrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Sturdza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li T","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elzbieta","family":"van der Steen-Banasik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Zapardiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remi A","family":"Nout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Fotopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2023.109589_b0005","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","article-title":"Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis","volume":"8","author":"Arbyn","year":"2020","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.radonc.2023.109589_b0010","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S1470-2045(20)30729-4","article-title":"WHO launches strategy to accelerate elimination of cervical cancer","volume":"22","author":"Das","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0015","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ejca.2021.07.039","article-title":"The European cancer burden in 2020: incidence and mortality estimates for 40 countries and 25 major cancers","volume":"157","author":"Dyba","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2023.109589_b0020","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/IGC.0000000000001216","article-title":"The European Society of Gynaecological Oncology\/European Society for Radiotherapy and Oncology\/European Society of Pathology guidelines for the management of patients with cervical cancer","volume":"28","author":"Cibula","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.radonc.2023.109589_b0025","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.radonc.2018.03.003","article-title":"The European Society of Gynaecological Oncology\/European Society for Radiotherapy and Oncology\/European Society of Pathology guidelines for the management of patients with cervical cancer","volume":"127","author":"Cibula","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0030","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00428-018-2362-9","article-title":"The European Society of Gynaecological Oncology\/European Society for Radiotherapy and Oncology\/European Society of Pathology guidelines for the management of patients with cervical cancer","volume":"472","author":"Cibula","year":"2018","journal-title":"Virchows Arch"},{"key":"10.1016\/j.radonc.2023.109589_b0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/ijgc-2019-000878","article-title":"European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer","volume":"30","author":"Cibula","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.radonc.2023.109589_b0040","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.prro.2016.01.012","article-title":"Radiation therapy quality-of-care indicators for locally advanced cervical cancer: a consensus guideline","volume":"6","author":"Croke","year":"2016","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0045","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ejso.2018.10.051","article-title":"Quality indicators for the management of endometrial, cervical and ovarian cancer","volume":"45","author":"Bonte","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0050","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.3802\/jgo.2018.29.e83","article-title":"Quality indicators for cervical cancer care in Japan","volume":"29","author":"Watanabe","year":"2018","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0055","unstructured":"NHS. Cervical cancer, clinical quality performance indicators. 2016. Available: https:\/\/www.healthcareimprovementscotland.org\/idoc.ashx?docid=6d6ae7c8-b410-4b6f-8c77-54d68432d6fe&version=-1)."},{"key":"10.1016\/j.radonc.2023.109589_b0060","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/intqhc\/mzg081","article-title":"Defining and classifying clinical indicators for quality improvement","volume":"15","author":"Mainz","year":"2003","journal-title":"Int J Qual Health Care"},{"key":"10.1016\/j.radonc.2023.109589_b0065","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ijgo.13865","article-title":"Cancer of the cervix uteri: 2021 update","volume":"155","author":"Bhatla","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.radonc.2023.109589_b0070","doi-asserted-by":"crossref","first-page":"512","DOI":"10.5114\/jcb.2021.110273","article-title":"Quantitative and qualitative application of clinical drawings for image-guided brachytherapy in cervical cancer patients","volume":"13","author":"Mahantshetty","year":"2021","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.radonc.2023.109589_b0075","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1200\/JCO.2012.47.3520","article-title":"Prospective multicenter study evaluating the survival of patients with locally advanced cervical cancer undergoing laparoscopic para-aortic lymphadenectomy before chemoradiotherapy in the era of positron emission tomography imaging","volume":"31","author":"Gouy","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0080","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1136\/ijgc-2020-001973","article-title":"Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB-IVA: oncologic results of a prospective randomized international multicenter (uterus-11) intergroup study","volume":"30","author":"Marnitz","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.radonc.2023.109589_b0085","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1097\/IGC.0000000000000211","article-title":"Effect of treatment delay on survival in patients with cervical cancer: a historical cohort study","volume":"24","author":"Perri","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.radonc.2023.109589_b0090","doi-asserted-by":"crossref","unstructured":"E C, Dahrouge S, Samant R, et al. Radical radiotherapy for cervix cancer: the effect of waiting time on outcome. Int J Radiat Oncol Biol Phys 2005;61:1071\u20137","DOI":"10.1016\/j.ijrobp.2004.09.030"},{"key":"10.1016\/j.radonc.2023.109589_b0095","doi-asserted-by":"crossref","first-page":"e0221946","DOI":"10.1371\/journal.pone.0221946","article-title":"Effect of time interval from diagnosis to treatment for cervical cancer on survival: a nationwide cohort study","volume":"14","author":"Chen","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.radonc.2023.109589_b0100","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/ijgc-00009577-200503000-00001","article-title":"Pattern of care and impact of participation in clinical studies on the outcome in ovarian cancer","volume":"15","author":"Du Bois","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.radonc.2023.109589_b0105","doi-asserted-by":"crossref","unstructured":"Rochon J, du Bois A. Clinical research in epithelial ovarian cancer and patients\u2019 outcome. Ann Oncol 2011;22:vii16\u20139","DOI":"10.1093\/annonc\/mdr421"},{"key":"10.1016\/j.radonc.2023.109589_b0110","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.radonc.2019.01.012","article-title":"Importance of training in external beam treatment planning for locally advanced cervix cancer: report from the embrace II dummy run","volume":"133","author":"Seppenwoolde","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0115","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ijrobp.2019.03.020","article-title":"Importance of technique, target selection, contouring, dose prescription, and dose-planning in external beam radiation therapy for cervical cancer: evolution of practice from EMBRACE-I to II","volume":"104","author":"Berger","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109589_b0120","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.brachy.2020.06.012","article-title":"Education and training for image-guided adaptive brachytherapy for cervix cancer-the (GEC)-ESTRO\/EMBRACE perspective","volume":"19","author":"Tan","year":"2020","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2023.109589_b0125","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.radonc.2020.02.017","article-title":"Implementing an online radiotherapy quality assurance programme with supporting continuous medical education - report from the EMBRACE-II evaluation of cervix cancer IMRT contouring","volume":"147","author":"Duke","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0130","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1200\/JCO.2017.75.9985","article-title":"Neoadjuvant chemotherapy followed by radical surgery versus concomitant chemotherapy and radiotherapy in patients with stage IB2, IIA, or IIb squamous cervical cancer: a randomized controlled trial","volume":"36","author":"Gupta","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0135","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1200\/JCO.2019.37.15_suppl.5503","article-title":"Results from neoadjuvant chemotherapy followed by surgery compared to chemoradiation for stage IB2-IIB cervical cancer, EORTC 55994","volume":"37","author":"Kenter","year":"2019","journal-title":"JCO"},{"key":"10.1016\/j.radonc.2023.109589_b0140","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","article-title":"MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study","volume":"22","author":"P\u00f6tter","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0145","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ijrobp.2014.07.017","article-title":"National cancer data base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements","volume":"90","author":"Gill","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109589_b0150","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijrobp.2013.05.033","article-title":"Trends in the utilization of brachytherapy in cervical cancer in the United States","volume":"87","author":"Han","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109589_b0155","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ijrobp.2019.10.042","article-title":"A phase II trial of stereotactic ablative radiation therapy as a boost for locally advanced cervical cancer","volume":"106","author":"Albuquerque","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109589_b0160","first-page":"386","article-title":"Brachytherapy: an overview for clinicians","volume":"69","author":"Chargari","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.radonc.2023.109589_b0165","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1200\/JCO.2017.77.4273","article-title":"Patient-reported toxicity during pelvic intensity-modulated radiation therapy: NRG oncology-RTOG 1203","volume":"36","author":"Klopp","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0170","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1200\/JCO.19.02381","article-title":"Improvement in patient-reported outcomes with intensity-modulated radiotherapy (RT) compared with standard RT: a report from the NRG oncology RTOG 1203 study","volume":"38","author":"Yeung","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0175","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1200\/JCO.20.02530","article-title":"Late toxicity after adjuvant conventional radiation versus image-guided intensity-modulated radiotherapy for cervical cancer (PARCER): a randomized controlled trial","volume":"39","author":"Chopra","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0180","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.clon.2013.11.031","article-title":"A systematic review of organ motion and image-guided strategies in external beam radiotherapy for cervical cancer","volume":"26","author":"Jadon","year":"2014","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2023.109589_b0185","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.radonc.2018.05.016","article-title":"Bowel morbidity following radiochemotherapy and image-guided adaptive brachytherapy for cervical cancer: physician- and patient reported outcome from the EMBRACE study","volume":"127","author":"Jensen","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0190","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.radonc.2016.08.004","article-title":"Impact of organ shape variations on margin concepts for cervix cancer art","volume":"120","author":"Seppenwoolde","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0195","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.radonc.2019.08.004","article-title":"Vienna-II ring applicator for distal parametrial\/pelvic wall disease in cervical cancer brachytherapy: an experience from two institutions: clinical feasibility and outcome","volume":"141","author":"Mahantshetty","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0200","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.radonc.2007.12.017","article-title":"Motion and deformation of the target volumes during IMRT for cervical cancer: what margins do we need?","volume":"88","author":"van de Bunt","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0205","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/mp.12818","article-title":"CBCT-guided evolutive library for cervical adaptive IMRT","volume":"45","author":"Rigaud","year":"2018","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2023.109589_b0210","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ijrobp.2014.06.046","article-title":"Clinical implementation of an online adaptive plan-of-the-day protocol for nonrigid motion management in locally advanced cervical cancer IMRT","volume":"90","author":"Heijkoop","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109589_b0215","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.phro.2021.11.002","article-title":"Comparison of library of plans with two daily adaptive strategies for whole bladder radiotherapy","volume":"20","author":"den Boer","year":"2021","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0220","unstructured":"Tanderup K, P\u00f6tter R. Image guided intensity modulated external beam radiochemotherapy and MRI based adaptive brachytherapy in locally advanced cervical cancer EMBRACE-II protocol. n.d. Available: https:\/\/www.embracestudy.dk\/UserUpload\/PublicDocuments\/EMBRACE%20II%20Protocol.pdf)."},{"key":"10.1016\/j.radonc.2023.109589_b0225","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.radonc.2016.06.006","article-title":"Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: results from the prospective multicenter embrace study","volume":"120","author":"Mazeron","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0230","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0360-3016(98)00482-9","article-title":"FIGO IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy","volume":"43","author":"Logsdon","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109589_b0235","doi-asserted-by":"crossref","unstructured":"K Jensen NB, P\u00f6tter R, Spampinato S, et al. Dose-volume effects and risk factors for late diarrhea in cervix cancer patients after radiochemotherapy with image guided adaptive brachytherapy in the embrace I study. Int J Radiat Oncol Biol Phys 2021;109:688\u2013700","DOI":"10.1016\/j.ijrobp.2020.10.006"},{"key":"10.1016\/j.radonc.2023.109589_b0240","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.radonc.2021.08.020","article-title":"Risk factors for nodal failure after radiochemotherapy and image guided brachytherapy in locally advanced cervical cancer: an embrace analysis","volume":"163","author":"Peters","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0245","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.7150\/jca.29301","article-title":"Efficacy and toxicity of IMRT-based simultaneous integrated boost for the definitive management of positive lymph nodes in patients with cervical cancer","volume":"10","author":"Dang","year":"2019","journal-title":"J Cancer"},{"key":"10.1016\/j.radonc.2023.109589_b0250","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1748-717X-9-83","article-title":"IMRT with 18FDG-PET\\CT based simultaneous integrated boost for treatment of nodal positive cervical cancer","volume":"9","author":"Cihoric","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0255","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.3109\/0284186X.2015.1061693","article-title":"Impact of radiation dose and standardized uptake value of (18) FDG PET on nodal control in locally advanced cervical cancer","volume":"54","author":"Ramlov","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0260","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ijrobp.2003.12.038","article-title":"Lymph node control in cervical cancer","volume":"59","author":"Grigsby","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109589_b0265","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ygyno.2017.12.028","article-title":"Dose-volume effects in pathologic lymph nodes in locally advanced cervical cancer","volume":"148","author":"Bacorro","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0270","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.brachy.2016.11.016","article-title":"Contribution of image-guided adaptive brachytherapy to pelvic nodes treatment in locally advanced cervical cancer","volume":"16","author":"Bacorro","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2023.109589_b0275","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.brachy.2014.07.005","article-title":"Assessment of radiation doses to the para-aortic, pelvic, and inguinal lymph nodes delivered by image-guided adaptive brachytherapy in locally advanced cervical cancer","volume":"14","author":"Mohamed","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2023.109589_b0280","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.radonc.2007.04.012","article-title":"Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer","volume":"83","author":"P\u00f6tter","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0285","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ygyno.2017.01.033","article-title":"Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer: a systematic review and meta-analysis","volume":"145","author":"Datta","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0290","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ygyno.2014.02.004","article-title":"Distant metastasis in patients with cervical cancer after primary radiotherapy with or without chemotherapy and image guided adaptive brachytherapy","volume":"133","author":"Schmid","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0295","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.3390\/jcm9061653","article-title":"Interaction between the number of chemotherapy cycles and brachytherapy dose\/volume parameters in locally advanced cervical cancer patients","volume":"9","author":"Escande","year":"2020","journal-title":"JCM"},{"key":"10.1016\/j.radonc.2023.109589_b0300","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.radonc.2012.04.007","article-title":"Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in france: results of the french STIC prospective study","volume":"103","author":"Charra-Brunaud","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0305","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.brachy.2016.05.009","article-title":"Tumor dose-volume response in image-guided adaptive brachytherapy for cervical cancer: a meta-regression analysis","volume":"15","author":"Mazeron","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2023.109589_b0310","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.radonc.2004.12.015","article-title":"Recommendations from gynaecological (GYN) GEC-ESTRO working group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV","volume":"74","author":"Haie-Meder","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0315","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.clon.2021.10.010","article-title":"Set-up errors, organ motion, tumour regression and its implications on internal target volume-planning target volume during cervical cancer radiotherapy: results from a prospective study","volume":"34","author":"Mahantshetty","year":"2022","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2023.109589_b0320","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.brachy.2016.08.009","article-title":"Combining transrectal ultrasound and CT for image-guided adaptive brachytherapy of cervical cancer: proof of concept","volume":"15","author":"Nesvacil","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2023.109589_b0325","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ijrobp.2010.10.030","article-title":"International brachytherapy practice patterns: a survey of the gynecologic cancer intergroup (GCIG)","volume":"82","author":"Viswanathan","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109589_b0330","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.brachy.2020.03.008","article-title":"Hypnosedation for endocavitary uterovaginal applications: a pilot study","volume":"19","author":"Kissel","year":"2020","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2023.109589_b0335","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.adro.2020.04.034","article-title":"Brachytherapy issues and priorities in the context of the coronavirus disease 2019 (COVID-19) outbreak","volume":"5","author":"Chargari","year":"2020","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0340","first-page":"48","article-title":"The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies","volume":"9","author":"P\u00f6tter","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0345","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.ijrobp.2019.12.019","article-title":"Ring versus ovoids and intracavitary versus intracavitary-interstitial applicators in cervical cancer brachytherapy: results from the EMBRACE I study","volume":"106","author":"Serban","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109589_b0350","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.semradonc.2020.05.008","article-title":"Evidence-based dose planning aims and dose prescription in image-guided brachytherapy combined with radiochemotherapy in locally advanced cervical cancer","volume":"30","author":"Tanderup","year":"2020","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0355","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ijrobp.2018.06.014","article-title":"Tumor shrinkage during chemoradiation in locally advanced cervical cancer patients: prognostic significance, and impact for image-guided adaptive brachytherapy","volume":"102","author":"Schernberg","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109589_b0360","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.radonc.2016.05.014","article-title":"Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer","volume":"120","author":"Tanderup","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0365","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.radonc.2016.03.020","article-title":"Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: analysis from the retroEMBRACE study","volume":"120","author":"Fokdal","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0370","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.brachy.2016.04.006","article-title":"Image-guided adaptive brachytherapy in cervical cancer: patterns of relapse by brachytherapy planning parameters","volume":"15","author":"Chargari","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2023.109589_b0375","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.3390\/jcm9113471","article-title":"Prognostic significance of tumor regression rate during concurrent chemoradiotherapy in locally advanced cervix cancer: analysis by radiation phase and histologic type","volume":"9","author":"Kang","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.radonc.2023.109589_b0380","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0360-3016(01)01808-9","article-title":"Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging","volume":"52","author":"Mayr","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109589_b0385","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ygyno.2007.06.022","article-title":"The prognostic significance of tumor volume regression during radiotherapy and concurrent chemoradiotherapy for cervical cancer using MRI","volume":"107","author":"Nam","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0390","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ijrobp.2021.04.022","article-title":"Nomogram predicting overall survival in patients with locally advanced cervical cancer treated with radiochemotherapy including image-guided brachytherapy: a retro-EMBRACE study","volume":"111","author":"Sturdza","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109589_b0395","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijrobp.2005.04.025","article-title":"Conventional, conformal, and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer: the impact of tumor regression","volume":"64","author":"van de Bunt","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109589_b0400","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.radonc.2014.11.045","article-title":"Impact of treatment time and dose escalation on local control in locally advanced cervical cancer treated by chemoradiation and image-guided pulsed-dose rate adaptive brachytherapy","volume":"114","author":"Mazeron","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0405","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3390\/jcm8010125","article-title":"Total reference air kerma is associated with late bowel morbidity in locally advanced cervical cancer patients treated with image-guided adaptive brachytherapy","volume":"8","author":"Bockel","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.radonc.2023.109589_b0410","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ijrobp.2018.02.004","article-title":"Risk of late urinary complications following image guided adaptive brachytherapy for locally advanced cervical cancer: refining bladder dose-volume parameters","volume":"101","author":"Manea","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109589_b0415","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.radonc.2021.01.019","article-title":"Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: an EMBRACE analysis","volume":"158","author":"Spampinato","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0420","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.radonc.2020.10.003","article-title":"Importance of the ICRU bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: an embrace analysis","volume":"158","author":"Spampinato","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0425","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.ijrobp.2021.09.055","article-title":"Severity and persistency of late gastrointestinal morbidity in locally advanced cervical cancer: lessons learned from EMBRACE-I and implications for the future","volume":"112","author":"Spampinato","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109589_b0430","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.radonc.2016.05.029","article-title":"A volumetric analysis of gtvd and ctvhr as defined by the GEC ESTRO recommendations in FIGO stage iib and IIIB cervical cancer patients treated with IGABT in a prospective multicentric trial (EMBRACE)","volume":"120","author":"Jastaniyah","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0435","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.ijrobp.2015.08.007","article-title":"Assessment of parametrial response by growth pattern in patients with International Federation of Gynecology and Obstetrics stage IIb and IIIB cervical cancer: analysis of patients from a prospective, multicenter trial (EMBRACE)","volume":"93","author":"Yoshida","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109589_b0440","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.radonc.2016.03.011","article-title":"Image guided brachytherapy in locally advanced cervical cancer: improved pelvic control and survival in retroEMBRACE, a multicenter cohort study","volume":"120","author":"Sturdza","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0445","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.clon.2015.10.008","article-title":"45 or 50 gy, which is the optimal radiotherapy pelvic dose in locally advanced cervical cancer in the perspective of reaching magnetic resonance image-guided adaptive brachytherapy planning aims?","volume":"28","author":"Mazeron","year":"2016","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2023.109589_b0450","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.radonc.2016.05.002","article-title":"Multicentre evaluation of a novel vaginal dose reporting method in 153 cervical cancer patients","volume":"120","author":"Westerveld","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0455","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.radonc.2021.12.034","article-title":"Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer: an EMBRACE-I sub-study","volume":"168","author":"Westerveld","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0460","unstructured":"ICRU report 89, prescribing, recording, and reporting brachytherapy for cancer of the cervix. n.d. Available: https:\/\/www.icru.org\/report\/icru-report-89-prescribing-recording-and-reporting-brachytherapy-for-cancer-of-the-cervix\/."},{"key":"10.1016\/j.radonc.2023.109589_b0465","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijrobp.2013.11.228","article-title":"Patterns of radiation therapy practice for patients treated for intact cervical cancer in 2005 to 2007: a quality research in radiation oncology study","volume":"89","author":"Eifel","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109589_b0470","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.brachy.2018.11.009","article-title":"Brachytherapy: a critical component of primary radiation therapy for cervical cancer: from the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS)","volume":"18","author":"Holschneider","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2023.109589_b0475","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijrobp.2015.01.037","article-title":"Trends in the quality of treatment for patients with intact cervical cancer in the United States, 1999 through 2011","volume":"92","author":"Smith","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109589_b0480","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.3109\/0284186X.2015.1063783","article-title":"Evaluation of planning aims and dose prescription in image-guided adaptive brachytherapy and radiochemotherapy for cervical cancer: Vienna clinical experience in 225 patients from 1998 to 2008","volume":"54","author":"Majercakova","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0485","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.ygyno.2020.03.006","article-title":"Comprehensive analysis of patient outcome after local recurrence of locally advanced cervical cancer treated with concomitant chemoradiation and image-guided adaptive brachytherapy","volume":"157","author":"Mignot","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0490","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/annonc\/mds217","article-title":"Controversies and challenges regarding the impact of radiation therapy on survival","volume":"24","author":"Chargari","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2023.109589_b0495","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00066-012-0156-6","article-title":"Do clinicians and patients agree regarding symptoms? A comparison after definitive radiochemotherapy in 223 uterine cervical cancer patients","volume":"188","author":"Kirchheiner","year":"2012","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2023.109589_b0500","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.ijrobp.2015.12.363","article-title":"Health-related quality of life in locally advanced cervical cancer patients after definitive chemoradiation therapy including image guided adaptive brachytherapy: an analysis from the EMBRACE study","volume":"94","author":"Kirchheiner","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109589_b0505","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ijrobp.2019.10.027","article-title":"Late, persistent, substantial, treatment-related symptoms after radiation therapy (LAPERS): a new method for longitudinal analysis of late morbidity-applied in the EMBRACE study","volume":"106","author":"Kirchheiner","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109589_b0510","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijrobp.2020.08.044","article-title":"Persistence of late substantial patient-reported symptoms (LAPERS) after radiochemotherapy including image guided adaptive brachytherapy for locally advanced cervical cancer: a report from the EMBRACE study","volume":"109","author":"Vittrup","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109589_b0515","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijrobp.2021.08.036","article-title":"Impact of vaginal symptoms and hormonal replacement therapy on sexual outcomes after definitive chemoradiotherapy in patients with locally advanced cervical cancer: results from the EMBRACE-I study","volume":"112","author":"Kirchheiner","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023001275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023001275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:30:25Z","timestamp":1759123825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814023001275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":103,"alternative-id":["S0167814023001275"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109589","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ESGO\/ESTRO quality indicators for radiation therapy of cervical cancer","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109589","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V and BMJ.  This is an open access article under the CC BY license (http:\/\/creativecommons.org\/licenses\/by\/4.0\/).","name":"copyright","label":"Copyright"}],"article-number":"109589"}}